|
1
|
Jabbour E and Kantarjian H: Chronic
myeloid leukemia: 2014 update on diagnosis, monitoring, and
management. Am J Hematol. 89:547–556. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dickinson AM, Pearce KF, Norden J, O'Brien
SG, Holler E, Bickeböller H, Balavarca Y, Rocha V, Kolb HJ,
Hromadnikova I, et al: Impact of genomic risk factors on outcome
after hematopoietic stem cell transplantation for patients with
chronic myeloid leukemia. Haematologica. 95:922–927. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rousselot P, Charbonnier A, Cony-Makhoul
P, Agape P, Nicolini FE, Varet B, Gardembas M, Etienne G, Réa D,
Roy L, et al: Loss of major molecular response as a trigger for
restarting tyrosine kinase inhibitor therapy in patients with
chronic-phase chronic myelogenous leukemia who have stopped
imatinib after durable undetectable disease. J Clin Oncol.
32:424–430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song P, Ye L, Fan J, Li Y, Zeng X, Wang Z,
Wang S, Zhang G, Yang P, Cao Z, et al: Asparaginase induces
apoptosis and cytoprotective autophagy in chronic myeloid leukemia
cells. Oncotarget. 6:3861–3873. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rahimi R, Mahdavi M, Pejman S, Zare P and
Balalaei S: Inhibition of cell proliferation and induction of
apoptosis in K562 human leukemia cells by the derivative (3-NpC)
from dihydro-pyranochromenes family. Acta Biochim Pol. 62:83–88.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Marchwicka A, Cebrat M, Sampath P,
Snieżewski L and Marcinkowska E: Perspectives of differentiation
therapies of acute myeloid leukemia: The search for the molecular
basis of patients' variable responses to 1,25-dihydroxyvitamin d
and vitamin d analogs. Front Oncol. 4:125–137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takahashi H, Hatta Y, Iriyama N, Hasegawa
Y, Uchida H, Nakagawa M, Makishima M, Takeuchi J and Takei M:
Induced differentiation of human myeloid leukemia cells into M2
acrophages by combined treatment with retinoic acid and
1α,25-dihydroxyvitamin D3. PLoS One. 9:e1137222014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu JL, Xue YC, Xie MY, Zhang R, Otani T,
Minami Y, Yamada Y and Marunaka T: A new macromolecular antitumor
antibiotic, C-1027. I. Discovery, taxonomy of producing organism,
fermentation and biological activity. J Antibiot (Tokyo).
41:1575–1579. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sakata N, Ikeno S, Hori M, Hamada M and
Otani T: Cloning and nucleotide sequencing of the antitumor
antibiotic C-1027 apoprotein gene. Biosci Biotechnol Biochem.
56:1592–1595. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tanaka T, Fukuda-Ishisaka S, Hirama M and
Otani T: Solution structures of C-1027 apoprotein and its complex
with the aromatized chromophore. J Mol Biol. 309:267–283. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shao RG and Zhen YS: Relationship between
the molecular composition of C1027, a new macromolecular antibiotic
with enediyne chromophore, and its antitumor activity. Yao Xue Xue
Bao. 30:336–342. 1995.(In Chinese). PubMed/NCBI
|
|
12
|
Jiang W, Shang B, Li L, Zhang S and Zhen
Y: Construction of a genetically engineered chimeric apoprotein
consisting of sequences derived from lidamycin and
neocarzinostatin. Anticancer Drugs. 27:24–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dziegielewski J and Beerman TA: Cellular
responses to the DNA strand-scission enediyne C-1027 can be
independent of ATM, ATR, and DNA-PK kinases. J Biol Chem.
277:20549–20554. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhen YS, Ming XY, Yu B, Otani T, Saito H
and Yamada Y: A new macromolecular antitumor antibiotic, C-1027.
III. Antitumor activity. J Antibiot (Tokyo). 42:1294–1298. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu YJ, Zhen YS and Goldberg IH: C1027
chromophore, a potent new enediyne antitumor antibiotic, induces
sequence-specific double-strand DNA cleavage. Biochemistry.
33:5947–5954. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhen H, Xue Y and Zhen Y: Inhibition of
angiogenesis by antitumor antibiotic C1027 and its effect on tumor
metastasis. Zhonghua Yi Xue Za Zhi. 77:657–660. 1997.(In Chinese).
PubMed/NCBI
|
|
17
|
Huang YH, Shang BY and Zhen YS: Antitumor
efficacy of lidamycin on hepatoma and active moiety of its
molecule. World J Gastroenterol. 11:3980–3984. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ding LL, Liu M, Zhang SH, Zhao XZ, Wu N,
Chen L, Wang GJ and Lin XK: Lidamycin inhibits angiogenesis of
zebrafish embryo via down-regulation of VEGF. Yao Xue Xue Bao.
45:456–461. 2010.(In Chinese). PubMed/NCBI
|
|
19
|
Shao RG and Zhen YS: Enediyne anticancer
antibiotic lidamycin: Chemistry, biology and pharmacology.
Anticancer Agents Med Chem. 8:123–131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suzuki M, Tanaka H, Tanimura A, Tanabe K,
Oe N, Rai S, Kon S, Fukumoto M, Takei K, Abe T, et al: The clathrin
assembly protein PICALM is required for erythroid maturation and
transferrin internalization in mice. PLoS One. 7:e318542012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xin C, Ye S, Ming Y, Shenghua Z, Qingfang
M, Hongxing G, Xu S, Yuanfu X, Yuan Z, Dongmei F, et al: Efficient
inhibition of B-cell lymphoma xenografts with a novel recombinant
fusion protein: anti-CD20Fab-LDM. Gene Ther. 17:1234–1243. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morgan CW, Julien O, Unger EK, Shah NM and
Wells JA: Turning on caspases with genetics and small molecules.
Methods Enzymol. 544:179–213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao Y, Lei M, Wang Z, Qiao G, Yang T and
Zhang J: TC R-induced, PKC-θ-mediated NF-κB activation is regulated
by a caspase-8-caspase-9-caspase-3 cascade. Biochem Biophys Res
Commun. 450:526–531. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang Y, Kim YW, Yun J, Shin J and Kim A:
KLF1 stabilizes GATA-1 and TAL1 occupancy in the human β-globin
locus. Biochim Biophys Acta. 1849:282–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Welch JJ, Watts JA, Vakoc CR, Yao Y, Wang
H, Hardison RC, Blobel GA, Chodosh LA and Weiss MJ: Global
regulation of erythroid gene expression by transcription factor
GATA-1. Blood. 104:3136–3147. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng Y, Wu W, Kumar SA, Yu D, Deng W,
Tripic T, King DC, Chen KB, Zhang Y, Drautz D, et al: Erythroid
GATA1 function revealed by genome-wide analysis of transcription
factor occupancy, histone modifications, and mRNA expression.
Genome Res. 19:2172–2184. 2009. View Article : Google Scholar : PubMed/NCBI
|
